Capricor Therapeutics Q3 EPS $(0.73) Misses $(0.05) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Misses
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.05) by 1360 percent. This is a 35.19 percent decrease over losses of $(0.54) per
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.05) by 1360 percent. This is a 35.19 percent decrease over losses of $(0.54) per share from the same period last year.